MAY 10, 2016 08:00 AM PDT

The art of war, unleashing the immune system to fight cancer

Speakers
  • Senior Principal Investigator and Director for Translational Immunology, Institute of Molecular and Cellular Biology (IMCB)
    Biography
      Dr. Connolly is a Senior Principal Investigator and Director for Translational Immunology at the Institute of Molecular and Cellular Biology (IMCB). Additionally, Dr. Connolly serves as Program Director for the A*Star Program in Translational Research in Infectious Disease, a multi-disciplinary center focused on vaccine development. As a human immunologist, his research focuses on immunotherapy for cancer and target discovery for immune modulation. In 2010 Dr. Connolly moved to Singapore to establish the Program in Translational Immunology at A*Star (Agency for Science, Technology and Research) a national training and infrastructure program linking all of the hospitals in Singapore and dedicated to the analysis of human disease in this uniquely diverse population. Dr. Connolly is Adjunct Associate Professor of Immunology at Baylor University.

      Dr. Connolly received his Ph.D. in Immunology from Dartmouth Medical School and studied human dendritic cell biology under Dr. Michael Fanger. During this time he was involved in the development of immunotherapeutic preclinical models and clinical trials for Glioblastoma multiforme (GBM). He moved to the Baylor Institute for Immunology Research, a fully translational research institute dedicated to rationally designed biologics, vaccines and cell therapy for cancer. Dr. Connolly served as the Director of Research Initiatives for the Baylor Research Institute, a large integrated translational research resource and multi-institutional programs that involved a number of international sites. During his tenure at Baylor, Dr. Connolly was the central core facility director of the NIAID Centers for Translational Research on Human Immunology and Biodefense, an NIH funded consortium of basic, translational research and clinical trials focused on vaccine design. Dr. Connolly is the past President of the Board of Directors of The American Cancer Society in N. Texas and founding Director of the Singapore Immunology Network's Immunomonitoring Platform.

    Abstract:
    DATE: May 10th, 2016
    TIME:  8:00am Pacific time, 11:00am Eastern time


    Cancer is a complex, multifactorial disease that not only is a cause of major human suffering throughout history, but continues to represent an enormous burden to society. In most cases long term treatment remains elusive primarily because the underlying cause does not often lie in a single defect but rather large number of small effects arising from lifestyle, environment and underlying genetic predispositions. Recent advances in our understanding of the human immune system and cancer immune evasion have led to nothing less than a revolution in cancer treatment. The development of effective immune checkpoint inhibitors, and novel cell therapy strategies have resulted unprecedented responses across a number indications with dramatic increases in durable disease control and long term survival. We will discuss the evolution of our view of the immune system and highlight the breakthroughs which provide a framework to develop the next generation of cancer therapeutics

    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    MAY 21, 2019 07:00 AM PDT
    C.E. CREDITS
    MAY 21, 2019 07:00 AM PDT
    DATE: May 21, 2019TIMEL 7:00am PT, 10:00am ET Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioriti...
    Loading Comments...
    Show Resources